IUSDF yields 3.09% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, IUSDF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IUSDF + PFE for your $10,000?
AS ONE Corporation engages in the sale of research instruments and equipment, nursing and care products, and other scientific instruments in Japan and internationally. It offers scientific instruments comprising temperature/humidity control and measuring/surveying instruments, as well as universal products used for cooling, heating, mixing, absorption, pressurization, and conveyance; microscopes, glass slides, and tissue culture products for biotechnology; magnifying glasses indispensable for precision work, plus filters, and dispensing devices required for analysis technology; equipment indispensable for research facilities, such as experimental platforms, fume hoods, and pharmaceutical depositories, as well as storage equipment, wagons, laboratory chairs, and conveyance equipment; containers required for storage or preservation of samples, reagents, materials, and others; glass or plastic beakers, flask indispensables, hoses, tubes, and joints; tapes and labels; and timers, packaging machines, tools, office supplies, and other equipment for laboratories. The company also provides industrial instruments, such as dehumidifying storage products; equipment for organization, conveyance, etc.; equipment for sterilization/disinfecting and cleaning, including ultrasonic cleaners for washing/drying, detergents, and drying tools; glasses, masks, and gloves; and tools and containers used in clean rooms, as well as dust-proof and anti-static products comprising clean room clothes and mats indispensable. In addition, it offers hospital/nursing instruments, such as white gowns, masks, and gloves; rack systems to be installed in nursing stations; various products, supplies, and equipment required for hospital nursing or care; and sterilizers and sterilization lockers, as well as care cars and beds, and bathing and sanitary products. The company was founded in 1933 and is headquartered in Osaka, Japan.
Full IUSDF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.